Literature DB >> 3012246

Skeletal alkaline phosphatase activity as a bone formation index in vitro.

J R Farley, D J Baylink.   

Abstract

These studies were intended to examine the relationship between skeletal collagen formation and skeletal alkaline phosphatase (ALP) activity in vitro. Embryonic chick calvaria were exposed to skeletal effectors (including high and low pH, a range of [pi] and [Ca], PTH, NaF, etc), and collagen formation was assessed by the incorporation of 3[H]-proline as 3[H]-hydroxyproline (3[H]-hyp). ALP activity was measured in the serum-free conditioned medium and in 20% butanol extracts of the bones. We found that ALP activity and 3[H]-hyp incorporation were coordinately increased from pH 5.5 to pH 7.2 (r = .99, P less than 0.001). Calvarial ALP was not increased in response to low [Pi], but low [Ca] increased ALP and coordinately decreased collagen formation (r = -.81, P less than 0.05). Although calvarial ALP and 3[H]-hyp incorporation were coordinately increased by NaF, vanadate, PGE2, calcitonin, and insulin, the slopes of the correlations were not the same for all effectors (eg, NaF: r = .97, P less than 0.01, slope = 0.90; vanadate, r = .95, P less than 0.005, slope = 0.20), indicating differential actions on ALP and 3[H]-hyp incorporation. When a variety of effectors, including low [Ca], were used to treat different groups of calvaria, ALP activity was not correlated with 3[H]-hyp incorporation (r = .35), but when the exposure to effectors was limited to a preincubation, or when the low [Ca] data were excluded, a correlation was observed (r = .87, P less than 0.001, and r = .64, P less than 0.02, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3012246     DOI: 10.1016/0026-0495(86)90016-8

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  28 in total

1.  Serum markers of bone formation in parenteral nutrition patients.

Authors:  E W Lipkin; S M Ott; G L Klein; L J Deftos
Journal:  Calcif Tissue Int       Date:  1990-08       Impact factor: 4.333

2.  The increase in spinal bone density that occurs in response to fluoride therapy for osteoporosis is not maintained after the therapy is discontinued.

Authors:  J R Talbot; M M Fischer; S M Farley; C Libanati; J Farley; A Tabuenca; D J Baylink
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

3.  Prognostic risk factors in patients with bone metastasis from colorectal cancer.

Authors:  Fangqi Liu; Jiang Zhao; Jie Xie; Li Xie; Ji Zhu; Sanjun Cai; Hongtu Zheng; Ye Xu
Journal:  Tumour Biol       Date:  2016-10-12

Review 4.  Membrane--vanadium interaction: a toxicokinetic evaluation.

Authors:  R K Upreti
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

5.  Calcitonin has direct effects on 3[H]-thymidine incorporation and alkaline phosphatase activity in human osteoblast-line cells.

Authors:  J R Farley; J E Wergedal; S L Hall; S Herring; N M Tarbaux
Journal:  Calcif Tissue Int       Date:  1991-05       Impact factor: 4.333

6.  Calcitonin (but not calcitonin gene-related peptide) increases mouse bone cell proliferation in a dose-dependent manner, and increases mouse bone formation, alone and in combination with fluoride.

Authors:  J R Farley; S L Hall; N M Tarbaux
Journal:  Calcif Tissue Int       Date:  1989-10       Impact factor: 4.333

7.  Evaluation of the usefulness of serum phosphatases and osteocalcin as serum markers in a calcium depletion-repletion rat model.

Authors:  H Tanimoto; K H Lau; S K Nishimoto; J E Wergedal; D J Baylink
Journal:  Calcif Tissue Int       Date:  1991-02       Impact factor: 4.333

8.  Aluminum stimulates the proliferation and differentiation of osteoblasts in vitro by a mechanism that is different from fluoride.

Authors:  K H Lau; A Yoo; S P Wang
Journal:  Mol Cell Biochem       Date:  1991-07-10       Impact factor: 3.396

9.  Aluminum effects on blood chemistry and long bone development in the chick embryo.

Authors:  C E Firling; A R Severson; T A Hill
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

10.  Serum levels of bone alkaline phosphatase in breast and prostate cancers with bone metastasis.

Authors:  G Ramaswamy; V R Rao; L Krishnamoorthy; G Ramesh; R Gomathy; D Renukadevi
Journal:  Indian J Clin Biochem       Date:  2000-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.